These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10423645)

  • 1. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.
    van Wely M; Stoss M; Gorter RW
    Am J Ther; 1999 Jan; 6(1):37-43. PubMed ID: 10423645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
    Gorter RW; van Wely M; Reif M; Stoss M
    Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
    Stoss M; van Wely M; Musielsky H; Gorter RW
    Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
    Huber R; Klein R; Berg PA; Lüdtke R; Werner M
    J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
    Kelter G; Fiebig HH
    Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
    Maier G; Fiebig HH
    Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating unconventional therapies.
    Hajto T; Saller R
    CMAJ; 1998 Oct; 159(7):759; author reply 759, 761. PubMed ID: 9805018
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
    Gorter RW; van Wely M; Stoss M; Wollina U
    Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of IFN-gamma increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented viscum album L. extract.
    Stoss M; Gorter RW
    Nat Immun; 1998; 16(4):157-64. PubMed ID: 10366786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
    Stein G; Berg PA
    Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
    Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
    Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects.
    Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R
    J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of the common cold in healthy subjects during exposure to a lectin-rich and a lectin-poor mistletoe preparation in a randomized, double-blind, placebo-controlled study].
    Huber R; Klein R; Lüdtke R; Werner M
    Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):354-8. PubMed ID: 11799303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
    Büssing A
    Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
    Urech K; Schaller G; Jäggy C
    Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R; Sandvig K; Olsnes S
    Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
    Kunze E; Schulz H; Gabius HJ
    J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.